期刊論文| 1. | Barker-Collo, S.、Bennett, D. A.、Krishnamurthi, R. V.(2015)。Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the global burden of disease study 2013。Neuroepidemiology，45，203-214。   |
| 2. | Cui, Y.、Hao, K.、Takahashi, J.(2017)。Age-Specific Trends in the Incidence and In-Hospital Mortality of Acute Myocardial Infarction Over 30 Years in Japan--Report From the Miyagi AMI Registry Study。Cire J，81，520-528。 |
| 3. | Degano, I. R.、Salomaa, V.、Veronesi, G.(2015)。Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations。Heart，101，1413-1421。 |
| 4. | Rosamond, W. D.、Chambless, L. E.、Heiss, G.(2012)。Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008。Circulation，125，1848-1857。 |
| 5. | Baigent, C.、Keech, A.、Kearney, P. M.(2005)。Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins。Lancet，366，1267-1278。 |
| 6. | Lee, M.、Wu, Y. L.、Ovbiagele, B.(2016)。Trends in incident and recurrent rates of first-ever ischemic stroke in Taiwan between 2000 and 2011。J Stroke，18，60-65。 |
| 7. | Cholesterol Treatment Trialists' (CTT) Collaborators(2008)。Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis。Lancet，371，117-125。 |
| 8. | Wang, W.、Zhang, B.(2014)。Statins for the prevention of stroke: a meta-analysis of randomized controlled trials。PLoS One，9。 |
| 9. | Stone, N. J.、Robinson, J. G.、Lichtenstein, A. H.(2014)。2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines。Circulation，129，S1-S45。 |
| 10. | Thai, L. P.、Moss, J. R.、Godman, B.、Vitry, A. I.(2016)。Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme。Expert Rev Pharmacoecon Outcomes Res，16，419-433。 |
| 11. | Hennessy, D. A.、Tanuseputro, P.、Tuna, M.(2016)。Population health impact of statin treatment in Canada。Health Rep，27，20-28。 |
| 12. | Pencina, M. J.、Navar-Boggan, A. M.、D'Agostino, R. B.(2014)。Application of new cholesterol guidelines to a population-based sample。N Engl J Med，370，1422-1431。 |
| 13. | 中華民國血脂及動脈硬化學會(2008)。2008台灣地區血脂治療共識摘要。中華民國心臟學會會訊，2008(11月號)。 延伸查詢 |
| 14. | National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)(2002)。Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report。Circulation，106(25)，3143-3421。 |